The Grid
The Grid
About
  • Overview
  • Product
  • Customised Solutions
  • CRM Enrichment
  • For Salespersons
  • For Recruiters
  • Why Us
  • Competitive Edges
  • Our Data
  • Success Stories
  • For Marketers
DiscoveryPricingContact us
News
  • Latest news
  • News by Cision
The Grid
or
Visit filters
Profile
arrow
banner
AD

T-CYPHER BIO

Developing next-gen TCR therapies for cancer & autoimmune diseases through proprietary platform
🏢 SME
Last updated: 29 Oct 2024 |

saved-buttonSaved
exported-buttonExported
Headquarter
United Kingdom of Great Britain and Northern Ireland
Headcount
11-50
21 from social media
Industry
Others
Recent funding
info-icon
-

T-Cypher Bio is an innovative biotechnology company based in Oxford, UK, focused on developing next-generation TCR therapies for the treatment of cancer and autoimmune diseases. Our proprietary disease target and TCR discovery platform enable us to identify and develop TCRs against novel, differenti...See more

Industry & specialities
biotechcancertherapyTCRimmunotherapyautoimmune+4 more
Details
Headquarter
United Kingdom of Great Britain and Northern Ireland
Countries of operation
United Kingdom of Great Britain and Northern Ireland
Year founded
2021 (3 years)
Funding status
Private
Company type
SME

Contact

Address:
hidden.address
Phone number:
hidden.number
Company email:
Website:
hidden.website
Social media:
banner
AD
*This profile is created/compiled by The Grid to the best of our research ability, it is not currently maintained by or endorsed by .

Lookalike companies

* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.

Frequently Asked Questions (FAQ)

  • How long has T-CYPHER BIO been operating for?
  • What is the funding status of T-CYPHER BIO?
  • What is the address of T-CYPHER BIO?
  • Where is T-CYPHER BIO's headquarter?
  • What is T-CYPHER BIO's contact number?
  • Which countries does T-CYPHER BIO operate in?
  • What T-CYPHER BIO's spending power?
  • Does T-CYPHER BIO have a presence in the domain it operates in?
* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0.

Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.